Skip to main content
Clinical Trials/NCT01779115
NCT01779115Enrolling By InvitationNot Applicable

Computerized Registry of Diabetes Patients in a Large Health Maintenance Organization in Israel

Maccabi Healthcare Services, Israel1 site in 1 country126,000 target enrollmentStarted: January 1998Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Enrolling By Invitation
Sponsor
Enrollment
126,000
Locations
1
Primary Endpoint
Prevalence rates of Diabetes

Study Overview

Brief Summary

A computerized registry of diabetes patients in a large health maintenance organization in Israel. The registry is aimed to be used by health professionals to identify diabetes patients and to follow the courses of their illnesses and risk factors.

Detailed Description

The registry was initiated in 1998 by Maccabi Healthcare services, which is the second largest publicly funded HMO in Israel,serving 24% of the total population with a nationwide distribution.

The registry uses advanced information technology that integrates personal computerized community and hospital records, data from laboratory tests, dispensed medications, physiological signals, radiological images, and reports from investigations and procedures.

Study Design

Study Type
Observational
Observational Model
Case Only

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Diabetic patient was defined according to the criteria suggested by American Diabetes Association - symptoms diagnosed as diabetes and fasting plasma glucose >125 mg/dl (7.0 lmol/l) or casual (namely, any time of day without regard to time since last meal) plasma glucose concentration P200 mg/dl. In order to reach maximal validity, we also included any patient who answered to one of the following: (1) purchased at least two hypoglycemic medications or single insulin dose during 6 months. (2) Had HbA1c result of at least 7.25%. HbA1c of 6.5% was used as entry criterion to registry only when the patient was diagnosed as diabetic.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Prevalence rates of Diabetes

Time Frame: Up to 100 years

Secondary Outcomes

  • Rates of performance of eye examinations,blood and urine tests(up to 100 years)
  • Number and types of Drugs purchased(100 years)
  • Number of visits to physician offices(up to 100 years)

Investigators

Sponsor
Maccabi Healthcare Services, Israel
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Registry of Diabetes Patients in a Large... | Clinical Trial